The new guidelines for eradicating Helicobacter pylori – 5 facts you should know Review article
Article Sidebar
Published:
Mar 31, 2024
Keywords:
Helicobacter pylori, eradication, proton pump inhibitors
Main Article Content
Abstract
The article presents methods of detecting Helicobacter pylori infection, taking into account the principles of selecting invasive and non-invasive tests. It describes current guidelines regarding the choice of eradication therapy regimen and new data concerning the administration of specific probiotics.
Article Details
How to Cite
Gąsiorowska, A. (2024). The new guidelines for eradicating Helicobacter pylori – 5 facts you should know. Medycyna Faktow (J EBM), 17(1(62), 7-10. https://doi.org/10.24292/01.MF.0124.01
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Zamani M, Ebrahimtabar F, Zamani V et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2018; 47: 868-76.
2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori. Lyon (FR): International Agency for Research on Cancer. IARC Monogr Eval Carcinog Risks Hum. 1994; 61: 1-241.
3. Malfertheiner P, Megraud F, Rokkas T et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022, 71: 1724-62.
4. Jaroń K, Pietrzak A, Daniluk K et al. Diagnostic and therapeutic recommendations on Helicobacter pylori infection. Recommendations of the Working Group of the Polish Society of Gastroenterology. Gastroenterology Rev. 2023; 18(3): 225-48.
5. Chey WD, Leontiadis GI, Howden CW et al. ACG Clinical Guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017; 112: 212-39.
6. Fallone CA, Chiba N, van Zanten SV et al. The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology. 2016; 151: 51-69.e14.
7. Kuo CH, Lu CY, Shih HY et al. CYP2C19 polymorphism influences Helicobacter pylori eradication. World J Gastroenterol. 2014; 20: 16029-36.
8. Nyssen O, Bordin D, Tepes B et al. European registry on Helicobacter pylori management (HP-EUREG): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients. Gut. 2021; 70: 40-54.
9. Yang C, Liang L, Lv P et al. Effects of non-viable Lactobacillus reuteri combining with 14-day standard triple therapy on Helicobacter pylori eradication: a randomized double-blind placebo-controlled trial. Helicobacter. 2021; 26: e12856.
10. Szajewska H, Horvath A, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Aliment Pharmacol Ther. 2015; 41: 1237-45.
2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori. Lyon (FR): International Agency for Research on Cancer. IARC Monogr Eval Carcinog Risks Hum. 1994; 61: 1-241.
3. Malfertheiner P, Megraud F, Rokkas T et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022, 71: 1724-62.
4. Jaroń K, Pietrzak A, Daniluk K et al. Diagnostic and therapeutic recommendations on Helicobacter pylori infection. Recommendations of the Working Group of the Polish Society of Gastroenterology. Gastroenterology Rev. 2023; 18(3): 225-48.
5. Chey WD, Leontiadis GI, Howden CW et al. ACG Clinical Guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017; 112: 212-39.
6. Fallone CA, Chiba N, van Zanten SV et al. The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology. 2016; 151: 51-69.e14.
7. Kuo CH, Lu CY, Shih HY et al. CYP2C19 polymorphism influences Helicobacter pylori eradication. World J Gastroenterol. 2014; 20: 16029-36.
8. Nyssen O, Bordin D, Tepes B et al. European registry on Helicobacter pylori management (HP-EUREG): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients. Gut. 2021; 70: 40-54.
9. Yang C, Liang L, Lv P et al. Effects of non-viable Lactobacillus reuteri combining with 14-day standard triple therapy on Helicobacter pylori eradication: a randomized double-blind placebo-controlled trial. Helicobacter. 2021; 26: e12856.
10. Szajewska H, Horvath A, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Aliment Pharmacol Ther. 2015; 41: 1237-45.